Who Produces Glucagon? A Sourcing Guide for Peptide Buyers
Published: 15 7 月, 2026 19:09
Author: Scott Ahrens
Abstract: Glucagon is primarily produced via recombinant DNA technology in E. coli or yeast strains by specialized GMP-certified facilities. The peptide market, valued at over $40 billion (2024), shows a 7.5% CAGR driven by diabetes and metabolic therapies. Key brands (e.g., Novo Nordisk, Fresenius Kabi) differ in purity (>98% vs. 95%) and excipient profiles. Lyophilized powder offers superior stability over liquid formulations. Sourcing requires verifying ISO 9001, GMP, and COA certificates. Logistics demand cold chain (-20°C) and lyophilized storage to maintain bioactivity. This guide compares technical parameters, regulatory compliance, and application scopes for informed procurement.